8-KThe WireRoutine
Shareholder Vote
Filed Aug 13, 2025 · 10mo ago · Accession 0001193125-25-179466
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Aug 13, 2025
- Report date
- Aug 12, 2025
- Document
- d885835d8k.htm
- Size
- 140 KB